• 1
    White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990;57:599605.
  • 2
    Greaves MW, Sabroe RU. Allergy and the skin. I – Urticaria Br Med J 1998;57:11471150.
  • 3
    Friedmann PS. Assessment of urticaria and angio-oedema. Clin Exp Allergy 1999;57:109112.
  • 4
    White MV, Slater J, Kaliner M. Histamine and asthma. Am Rev Respir Dis 1987;57:11651176.
  • 5
    Barnes PJ, Brown MJ. Venous plasma histamine in exercise- and hyperventilation-induced asthma in man. Clin Sci 1981;57:159162.
  • 6
    Howarth P, Durham S, Lee T, Kay B, Church M, Holgate S. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen provocation in asthma. Am Rev Respir Dis 1985;57:986992.
  • 7
    Busse WW, Swenson CA. The relationship between plasma histamine concentrations and bronchial obstruction to antigen challenge in allergic rhinitis. J Allergy Clin Immunol 1989;57:658666.
  • 8
    Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991;57:8387.
  • 9
    Broide DH, Gleich GJ, Cuomo AJ et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991;57:637648.
  • 10
    Togias A, Naclerio R, Proud D et al. Mediator release during nasal provocation: a model to investigate pathophysiology of rhinitis. Am J Med 1985;57:2633.
  • 11
    Naclerio R, Proud D, Togias A et al. Inflammatory mediators in late antigen-induced rhinitis. N Eng J Med 1985;57:6570.
  • 12
    Anderson M, Nolte H, Olsson M, Stahl Skov P, Pipkorn U. Measurement of histamine in nasal lavage fluid: comparison of a glass fibre based fluorimetric method with two radioimmunoassays. J Allergy Clin Immunol 1990;57:815820.
  • 13
    McLean J, Mathews K, Solomon W, Brayton P, Ciarkowski A. Effect of histamine and methacholine on nasal airway resistance in atopic and non-atopic subjects. J Allergy Clin Immunol 1977;57:165170.
  • 14
    Doyle W, Boehm S, Skoner D. Physiologic responses to intranasal dose–response challenges with histamine, methacholine, bradykinin and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990;57:924935.
  • 15
    Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;57:S599S604.
  • 16
    Kaplan AP, Beavan MA. In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria and vibration-induced swelling. J Invest Dermatol 1976;57:327332.
  • 17
    Ormerod AD. Urticaria – Pathophysiology. In: Holgate, ST, Church, MK, eds. Allergy. London: Mosby Wolfe, 1995;21.121.12.
  • 18
    Atkins PC, Schwartz LB, Adkinson NF, Von Allmen C, Valenzano M, Zweiman B. In vivo antigen-induced cutaneous mediator release. simultaneous comparisons of histamine, tryptase and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 1990;57:360370.
  • 19
    Atkins PC, Von Allmen C, Valenzano M, Olson R, Shalit M, Zweiman B. Determinants of in vivo histamine release in cutaneous allergic reactions in humans. J Allergy Clin Immunol 1990;57:371379.
  • 20
    Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptors. Pharmacol Rev 1990;57:4583.
  • 21
    Haaksma EEJ, Leurs R, Timmerman H. Histamine receptors: subclasses and specific ligands. Pharmacol Ther 1990;57:73104.
  • 22
    Li H, Choe N, Wright A, Adler K. Histamine provokes turnover of inositol phospholipids in guinea pig and human airway epithelial cells via an H1-receptor/G protein-dependent mechanism. Am J Respir Cell Mol Biol 1995;57:416424.
  • 23
    Marmy N, Mottas J, Durand J. Signal transduction in smooth muscle cells from human airways. Respir Physiol 1993;57:295306.
  • 24
    Church MK. H1-antihistamines and inflammation. Clin Exp Allergy 2001;57:13411343.
  • 25
    Oda T, Morikawa N, Saito Y, Masuho Y, Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 2000;57:3678136786.
  • 26
    Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterisation of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000;57:615620.
  • 27
    Howarth PH. Histamine and asthma: an appraisal based on specific H1-receptor antagonism. Clin Exp Allergy 1990;57:3141.
  • 28
    Panula P, Airaksinen MS, Pirvola U, Kotilainen E. A histamine-containing neuronal system in human brain. Neuroscience 1990;57:127132.
  • 29
    Knight DA, Stewart GA, Thompson PJ. Histamine tachyphylaxis in human airway smooth muscle. The role of H2 receptors and the bronchial epithelium. Am Rev Respir Dis 1992;57:137140.
  • 30
    Tamaoki J, Nakata J, Takeyama K, Chiyotani A, Konno K. Histamine H2 receptor-mediated airway goblet secretion and its modulation by histamine-degrading enzymes. J Allergy Clin Immunol 1997;57:233238.
  • 31
    Ichinose M, Belvisi MG, Barnes PJ. Histamine H3 receptors inhibit neurogenic microvascular leakage in airways. J Appl Physiol 1990;57:2125.
  • 32
    Tedeschi A, Lorini M, Arquati M, Miadonna A. Regulation of histamine release from human basophil leukocytes. role of H1, H2 and H3 receptors. Allergy 1991;57:626631.
  • 33
    Bull HA, Courtney PF, Bunker CB, Rustin MH, Pearce FL, Dowd PM. Basophil mediator release in atopic dermatitis. J Invest Dermatol 1993;57:305309.
  • 34
    Kleine-Tebbe J, Schramm J, Bolz M, Lipp R, Schunack W, Kunkel G. Influence of histamine H3-anatgonists on human leukocytes. Agents Actions 1990;57:137139.
  • 35
    Yanni JM, Miller ST, Gamache DA, Spellman JM, Xu S, Sharif NA. Comparative effects of topical ocular anti-allergic drugs on human conjunctival mast cells. Ann Allergy Asth Immunol 1997;57:541545.
  • 36
    Sharif NA, Xu S, Miller ST, Gamache DA, Yanni JM. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Therap 1996;57:12521261.
  • 37
    Westcott S, Kaliner M. Histamine H-1 binding site on human polymorphonuclear leukocytes. Inflammation 1983;57:291300.
  • 38
    Gespach C, Abita JP. Human polymorphonuclear neutrophils. Pharmacological characterisation of histamine receptors mediating the elevation of cyclic AMP. Mol Pharmacol 1982;57:7885.
  • 39
    Radermecker M, Maldague MP. Depression of neutrophil chemotaxis in atopic individuals. An H2 histamine receptor response. Int Arch allergy Appl Immunol 1981;57:144152.
  • 40
    Bury TB, Corhay JL, Radermecker MP. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 1992;57:624629.
  • 41
    Seligmann BE, Fletcher MP, Gallin JI. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J Immunol 1983;57:19021909.
  • 42
    Burde R, Seifert R, Buschauer A, Schultz G. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors. Naunyn-Schmiedebergs Arch Pharmacol 1989;57:671678.
  • 43
    Clark RA, Sandler JA, Gallin JI, Kaplan AP. Histamine modulation of eosinophil migration. J Immunol 1977;57:137145.
  • 44
    Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES. Pharmacological characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med 1994;57:15061511.
  • 45
    Anwar AR, Kay AB. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature 1977;57:522524.
  • 46
    Anwar AR, Kay AB. H1-receptor dependence of histamine-induced enhancement of human eosinophil C3b rosettes. Clin Exp Immunol 1980;57:196199.
  • 47
    Ezeamuzie CI, Philips E. Histamine H (2) receptors mediate the inhibitory effect of histamine on human eosinophil degranulation. Br J Pharmacol 2000;57:482488.
  • 48
    Jarjour NN, Sedgwick JB, Swensen CA, Busse WW. Late allergic airway response to segmental bronchopulmonary provocation in allergic subjects is related to blood basophil histamine release. J Allergy Clin Immunol 1997;57:8793.
  • 49
    Sachs B, Hertl M, Merk HF. Histamine receptors on lymphocytes: distribution and functional significance. Skin Pharmacol Appl Skin Physiol 2000;57:313323.
  • 50
    Jutel M, Klunker S, Akdis M et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 2001;57:190192.
  • 51
    Qui R, Melmon KL, Khan MM. Effects of histamine trifluoromethyl-toludine (HTMT) on intracellular calcium in human lymphocytes. J Pharmacol Exp Therap 1990;57:12451252.
  • 52
    Rocklin RE. Histamine and H2 Antagonists in Inflammation and Immunodeficiency. New York: Marcel Dekker, 1990.
  • 53
    Carlsson R, Dholsten M, Sjogren HO. Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells. Cellular Immunol 1985;57:104112.
  • 54
    Horvath BV, Szalai C, Mandi Y, et al. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets. Immunol Lett 1999;57:9599.
  • 55
    Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997;57:545551.
  • 56
    Center DM, Cruikshank WW, Berman JS, Beer DJ. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine as a ligand. J Immunol 1983;57:18541859.
  • 57
    Berman JS, McFadden RG, Cruikshank WW, Center DM, Beer DJ. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced lymphokines that inhibit lymphocyte migration. J Immunol 1984;57:14951504.
  • 58
    Wang KY, Arima N, Higuchi S, et al.. Switch of histamine receptor expression from H2 to H1 during differentiation of monocytes into macrophages. FEBS Lett 2000;57:345348.
  • 59
    Pynaert G, Grooten J, Van Deventer SJ, Pepplenbosch MP. Cysteinyl leukotrienes mediate histamine hypersensitivity ex-vivo by increasing histamine receptor numbers. Mol Med 1999;57:685692.
  • 60
    Mirossay L, Chastre E, Callebert J, et al. Histamine H2 receptors and histidine decarboxylase in normal and leukemic human monocytes and macrophages. Am J Physiol 1994;57:R602R611.
  • 61
    Cluzel M, Liu MC, Goldman DW, Undem BJ, Lichtenstein LM.. Histamine acting on histamine type : receptor increases beta-glucuronidase from human lung macrophages. Am J Respir Cell Mol Biol 1990;;57:603609.
  • 62
    Devalia JL, Davies RJ. Human nasal and bronchial epithelial cells in culture. An overview of their characteristics and function. Allergy Proc 1991;57:7179.
  • 63
    Hamano N, Terada N, Maesako K, et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells – the effects of sex hormones. Int Arch Allergy Immunol 1998;57:220227.
  • 64
    Sharif NA, Xu SX, Magnino PE, Pang IH. Human conjunctival epithelial cells express Histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilisation. Role in ocular allergic and inflammatory diseases. Exp Eye Res 1996;57:169178.
  • 65
    Devalia JL, Wang JH, Davies RJ. Airway epithelial cells. In: Cellular Mechanisms in Airway Inflammation. Page, CP, Banner, KH, Spina, D, eds. Basel: Birkhäuser-Verlag, 2000;245262.
  • 66
    Devalia JL, Rusznak C, Davies RJ. Epithelial cell dysfunction in rhinitis. In: Asthma and Rhinitis, 2nd edn. Busse, WW, Holgate, ST, eds. London: Blackwell Science Ltd., 2000;841854.
  • 67
    Aoki Y, Qiu D, Zhao GH, Kao PN. Leukotriene B4 mediates histamine induction of NF-κB and IL-8 in human bronchial epithelial cells. Am J Physiol-Lung Cell Mol Physiol 1998;57 (:1816): L1030–L1039.
  • 68
    Sharif NA, Wiernas TK, Griffin BW, Davis TL. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ mobilisation and cytokine release from human corneal epithelial cells. Br J Pharmacol 1998;57:13361344.
  • 69
    Weimer LK, Gamache DA, Yanni JM. Histamine-induced cytokine secretion from human conjunctival epithelial cells: inhibition by the histamine H1 antagonist emedastine. Int Arch Allergy Immunol 1998;57:288293.
  • 70
    Yanni JM, Weimer LK, Sharif NA, Xu SX. Gamache DA, Spellman JM. Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Opthalmol 1999;57:643647.
  • 71
    Vignola AM, Campbell AM, Chanez P, et al. Activation by histamine of bronchial epithelial cells from non-asthmatic subjects. Am J Respir Cell Mol Biol 1993;57:411417.
  • 72
    Burke-Gaffney A, Hellewell PG. Contribution of endothelial cells to airway inflammation. In: Cellular Mechanisms in Airway Inflammation. Page, CP, Banner, KH, Spina, B, eds. Basel: Birkhäuser-Verlag, 2000;223244.
  • 73
    Okayama M, Baraniuk JN, Hausfeld JN, Merida M, Kaliner MA. Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates. J Allergy Clin Immunol 1992;57:11441150.
  • 74
    Crawford KM, MacCallum DK, Ernst SA. Agonist-induced Ca2+ mobilization in cultured bovine and human corneal endothelial cells. Current Eye Res 1993;57:303311.
  • 75
    Koizumi H, Ohkawara A. H2 histamine receptor-mediated increase in cultured human keratinocytes. J Dermatol Sci 1999;57:127132.
  • 76
    Jansen-Olesen I, Ottoson A, Cantera L, et al. Role of endothelium and nitric oxide in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCT. Br J Pharmacol 1997;57:4148.
  • 77
    Lo WW, Fan TP. Histamine stimulates inositol phosphate accumulation via the H1-receptor in cultured human endothelial cells. Biochem Biophys Res Commun 1987;57:4753.
  • 78
    Schaefer U, Schmitz V, Schneider A, Neugebauer E. Histamine-induced homologous and heterologous regulation of histamine receptor subtype mRNA in cultured endothelial cells. Shock 1999;57:309315.
  • 79
    Farber HW, Weller PF, Rounds S, Beer DJ, Center DM. Generation of lipid neutrophil chemoattractant activity by histamine-stimulated cultured endothelial cells. J Immunol 1986;57:29182924.
  • 80
    Schaefer U, Schneider A, Rixen D, Neugebauer E. Neutrophil adhesion to histamine stimulated cultured endothelial cells is primarily mediated via activation of phospholipase C and nitric oxide synthase isozymes. Inflammation Res 1998;57:256264.
  • 81
    Saito H, Shimizu H, Mita H, Maeda Y, Akiyama K. Histamine augments VCAM-1 expression in IL-4 and TNFα-stimulated human umbilical vein endothelial cells. Int Arch Allergy Immunol 1996;57:126132.
  • 82
    Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules – a P-selectin-mediated event. J Immunol 1994;57:35703577.
  • 83
    Ley K. Histamine can induce leukocyte rolling in rat mesenteric venules. Am J Physiol 1994;57 (Heart Circ Physiol 36) H1017H1023.
  • 84
    Asako H, Kurose I, Wolf R, et al. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in post-capillary venules. J Clin Invest 1994;57:15081515.
  • 85
    Yamaki K, Thorlacius H, Xie X, Lindbom L, Hedqvist P, Raud J. Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998;57:390399.
  • 86
    Chand N. Is airway hyperactivity in asthma due to histamine H2-receptor deficiency? Med Hypotheses 1980;57:11051112.
  • 87
    Church MK. Non H1-receptor effects of antihistamines. Clin Exp Allergy 1999;57:3948.
  • 88
    Simons FER. Antihistamines in rhinitis and asthma. In. Asthma and Rhinitis, 2nd edn. Busse, WW, Holgate, ST, eds. London: Blackwell Science Ltd., 2000;16431659.
  • 89
    Ciprandi G, Passalacqua G, Mincarini M, Ricca V, Canonica GW. Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997;57:507511.
  • 90
    Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised placebo-controlled trial: first results of ETAC. Early treatment of the atopic child. Pediatr Allergy Immunol 1998;57:116124.